138
Participants
Start Date
August 12, 2016
Primary Completion Date
October 31, 2017
Study Completion Date
October 31, 2017
Arm 1: BreatheMate device with application
The service known as 'BreatheMate' is a patient support tool that monitors daily Symbicort inhaler use. The BreatheMate service includes a bluetooth monitoring device that is attached to subjects' Symbicort pMDI inhaler which automatically detects and logs their maintenance medication use. Subjects will receive audio-visual daily reminders (beeps and flashes) on the BreatheMate Bluetooth device. The bluetooth device transmits this data to a cellular phone that is provided to all subjects in the study. Subjects in the intervention group will also receive audio-visual alerts (beeps, flashes) from the bluetooth device to take their medication.
Arm 2: BreatheMate device without application
"The service known as 'BreatheMate' is a patient support tool that monitors daily Symbicort inhaler use. The BreatheMate service includes a bluetooth monitoring device that is attached to subjects' Symbicort pMDI inhaler which automatically detects and logs their maintenance medication use. The functionality of audio-visual daily reminders (beeps and flashes) is deactivated for this control group.~The BreatheMate service also includes a cellular phone that will display whether the Bluetooth monitoring device is paired and communicating with the cellular phone. The Bluetooth device will transmit data regarding medication usage to the cellular phone."
Research Site, Brooklyn
Research Site, Philadelphia
Research Site, Downingtown
Research Site, Charlotte
Research Site, Spartanburg
Research Site, Tampa
Research Site, Clearwater
Research Site, Marlton
Lead Sponsor
Quintiles, Inc.
INDUSTRY
AstraZeneca
INDUSTRY